These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors. Zuur CL; Simis YJ; Lamers EA; Hart AA; Dreschler WA; Balm AJ; Rasch CR Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):490-6. PubMed ID: 19135315 [TBL] [Abstract][Full Text] [Related]
45. Phase 1 study to evaluate safety, tolerability and pharmacokinetics of a novel intra-tympanic administered thiosulfate to prevent cisplatin-induced hearing loss in cancer patients. Viglietta V; Shi F; Hu QY; Ren Y; Keilty J; Wolff H; McCarthy R; Kropp J; Weber P; Soglia J Invest New Drugs; 2020 Oct; 38(5):1463-1471. PubMed ID: 32157599 [TBL] [Abstract][Full Text] [Related]
47. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma. Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645 [TBL] [Abstract][Full Text] [Related]
48. cis-platinum ototoxicity in children. Pasic TR; Dobie RA Laryngoscope; 1991 Sep; 101(9):985-91. PubMed ID: 1886448 [TBL] [Abstract][Full Text] [Related]
49. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec. Peleva E; Emami N; Alzahrani M; Bezdjian A; Gurberg J; Carret AS; Daniel SJ Pediatr Blood Cancer; 2014 Nov; 61(11):2012-7. PubMed ID: 24976616 [TBL] [Abstract][Full Text] [Related]
50. Hearing function in soft tissue sarcoma patients after treatment with carboplatin: a report from the Late Effects Surveillance System. Stöhr W; Langer T; Kremers A; Brecht I; Treuner J; Dinnesen A; Beck JD Oncol Rep; 2004 Oct; 12(4):767-71. PubMed ID: 15375498 [TBL] [Abstract][Full Text] [Related]
51. [Relieving effect of sodium thiosulfate on transarterial chemotherapeutic emesis]. Wang GH; Cao SW; Chen BH Zhonghua Hu Li Za Zhi; 1997 May; 32(5):251-3. PubMed ID: 9304980 [TBL] [Abstract][Full Text] [Related]
52. ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin. De Lauretis A; De Capua B; Barbieri MT; Bellussi L; Passàli D Scand Audiol; 1999; 28(3):139-43. PubMed ID: 10489862 [TBL] [Abstract][Full Text] [Related]
53. Practical grading system for evaluating cisplatin ototoxicity in children. Chang KW; Chinosornvatana N J Clin Oncol; 2010 Apr; 28(10):1788-95. PubMed ID: 20194861 [TBL] [Abstract][Full Text] [Related]
54. A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer. Rolland V; Meyer F; Guitton MJ; Bussières R; Philippon D; Bairati I; Leclerc M; Côté M J Otolaryngol Head Neck Surg; 2019 Jan; 48(1):4. PubMed ID: 30651130 [TBL] [Abstract][Full Text] [Related]
56. Sodium thiosulfate administered six hours after cisplatin does not compromise antineuroblastoma activity. Harned TM; Kalous O; Neuwelt A; Loera J; Ji L; Iovine P; Sposto R; Neuwelt EA; Reynolds CP Clin Cancer Res; 2008 Jan; 14(2):533-40. PubMed ID: 18223229 [TBL] [Abstract][Full Text] [Related]
57. Long-term audiologic follow-up of carboplatin-treated children with retinoblastoma. Geurtsen ML; Kors WA; Moll AC; Smits C Ophthalmic Genet; 2017; 38(1):74-78. PubMed ID: 27050825 [TBL] [Abstract][Full Text] [Related]
58. Assessment of provider perspectives on otoprotection research for children and adolescents: A Children's Oncology Group Cancer Control and Supportive Care Committee survey. Orgel E; Freyer DR; Ullrich NJ; Hardy KK; Thomas SM; Dvorak CC; Esbenshade AJ Pediatr Blood Cancer; 2020 Nov; 67(11):e28647. PubMed ID: 32886425 [TBL] [Abstract][Full Text] [Related]
59. Transtympanic Sodium Thiosulfate for Prevention of Cisplatin-Induced Ototoxicity: A Randomized Clinical Trial. Duinkerken CW; de Weger VA; Dreschler WA; van der Molen L; Pluim D; Rosing H; Nuijen B; Hauptmann M; Beijnen JH; Balm AJM; de Boer JP; Burgers JA; Marchetti S; Schellens JHM; Zuur CL Otol Neurotol; 2021 Jun; 42(5):678-685. PubMed ID: 33710154 [TBL] [Abstract][Full Text] [Related]
60. Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature. Meijer AJM; Diepstraten FA; Ansari M; Bouffet E; Bleyer A; Fresneau B; Geller JI; Huitema ADR; Kogner P; Maibach R; O'Neill AF; Papadakis V; Rajput KM; Veal GJ; Sullivan M; van den Heuvel-Eibrink MM; Brock PR J Clin Oncol; 2024 Jun; 42(18):2219-2232. PubMed ID: 38648563 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]